Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 28, 2023

BUY
$0.8 - $4.98 $2,773 - $17,265
3,467 Added 25.23%
17,206 $14,000
Q4 2022

Feb 02, 2023

SELL
$1.88 - $36.45 $7,666 - $148,643
-4,078 Reduced 22.89%
13,739 $33,000
Q3 2022

Oct 31, 2022

SELL
$2.5 - $37.95 $78,515 - $1.19 Million
-31,406 Reduced 63.8%
17,817 $40,000
Q2 2022

Jul 29, 2022

BUY
$1.75 - $11.34 $86,140 - $558,188
49,223 New
49,223 $121,000
Q1 2022

Apr 29, 2022

SELL
$10.21 - $20.29 $98,373 - $195,494
-9,635 Closed
0 $0
Q4 2021

Feb 07, 2022

SELL
$16.76 - $22.99 $165,052 - $226,405
-9,848 Reduced 50.55%
9,635 $190,000
Q3 2021

Nov 01, 2021

BUY
$13.15 - $22.56 $256,201 - $439,536
19,483 New
19,483 $360,000

Others Institutions Holding PRAX

# of Institutions
1
Shares Held
75K
Call Options Held
0
Put Options Held
0

About Praxis Precision Medicines, Inc.


  • Ticker PRAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,576,100
  • Market Cap $3.54B
  • Description
  • Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...
More about PRAX
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.